Alopurinol Indications Based on Uric Acid Levels
Indications for Alopurinol
- The American College of Rheumatology recommends alopurinol for patients with gout who have subcutaneous tophi, radiographic damage attributable to gout, or frequent gout attacks (>2/year), regardless of serum uric acid level 1
- For patients with their first gout attack and uric acid levels >9 mg/dl, the American College of Rheumatology recommends starting alopurinol even after the first episode 1, 2
- In patients with moderate to severe chronic kidney disease (stage ≥3) and first gout attack, the American College of Rheumatology recommends starting alopurinol 1
- For patients with urolithiasis and first gout attack, the American College of Rheumatology recommends starting alopurinol 1
- The American College of Rheumatology conditionally recommends starting alopurinol in patients who have experienced more than one attack but with infrequent attacks (<2/year) 1
Therapeutic Targets for Uric Acid
- The general therapeutic target is to maintain serum uric acid levels below 6 mg/dL (360 μmol/L) 3
- In patients with severe gout (tophi, chronic arthropathy, frequent attacks), the target should be more stringent: <5 mg/dL (300 μmol/L) 3
Special Considerations
In Renal Disease
- In patients with renal insufficiency, the dose of alopurinol should be reduced by 50% 4
In Tumor Lysis Syndrome
- For patients with pre-existing hyperuricemia (≥7.5 mg/dL) at risk of tumor lysis syndrome, rasburicase is preferred over alopurinol 4, 5
- Alopurinol only prevents the formation of uric acid and does not reduce uric acid produced before the start of treatment 5
Precautions and Practical Considerations
- Uric acid levels can fluctuate during acute gout attacks, behaving like a negative acute phase reactant 3
- Once started, alopurinol treatment should be maintained indefinitely, as its discontinuation leads to the recurrence of gout attacks 6
- Lifestyle modifications are complementary to pharmacological treatment, not a replacement 6